Kuo, Wei-Ying <br/><br/>
Antibody-drug conjugates with HER2-targeting antibodies from synthetic antibody libraries are highly potent against HER2-positive human gastric tumor in xenograft models.  [electronic resource] 

 -  mAbs  01 2019 
 - 153-165 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1942-0870 
<br/><br/><label>Standard No.: </label>10.1080/19420862.2018.1541370  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminobenzoates--pharmacology<br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Humans<br/>Immunoconjugates--pharmacology<br/>Mice<br/>Molecular Targeted Therapy--methods<br/>Oligopeptides--pharmacology<br/>Receptor, ErbB-2--antagonists & inhibitors<br/>Stomach Neoplasms--pathology<br/>Xenograft Model Antitumor Assays